Galmed Pharmaceuticals Ltd. buy Royal Bank of Canada
Start price
11.01.24
/
50%
€0.41
Target price
11.01.25
€63.93
Performance (%)
-14.49%
Price
19:34
€0.35
Summary
This prediction is currently active. The prediction for Galmed Pharmaceuticals Ltd. disappoints with a performance of -14.49%. This prediction currently runs until 11.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | 3.315% | 3.315% |
iShares Core DAX® | 1.851% | 5.158% |
iShares Nasdaq 100 | 1.573% | 2.589% |
iShares Nikkei 225® | -0.412% | -2.857% |
iShares S&P 500 | 1.128% | 2.485% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $70.00 price target on the stock.
Ratings data for GMED provided by MarketBeat